Paclitaxel-Coated Balloons in the Femoropopliteal Artery: It Is All About the Pharmacokinetic Profile and Vessel Tissue Bioavailability∗

JACC: Cardiovascular Interventions

Volumn 9, Issue 16, 2016, Pages 1743-1745

  Katsanos, Konstantinos ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

bioavailability; femoropopliteal; meta analysis; paclitaxel coated balloons; pharmacokinetics

Indexed keywords

PACLITAXEL;

BALLOON CATHETER; COST BENEFIT ANALYSIS; CRITICAL LIMB ISCHEMIA; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; EDITORIAL; FEMORAL ARTERY; FEMOROPOPLITEAL ARTERY; HUMAN; META ANALYSIS (TOPIC); PACLITAXEL COATED BALLOON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHARMACOKINETIC PARAMETERS; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BIOAVAILABILITY;

BIOLOGICAL AVAILABILITY; FEMORAL ARTERY; PACLITAXEL; POPLITEAL ARTERY;

EID: 84990935029     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.06.047     Document Type: Editorial

References (14)

1. 1 Diamantopoulos, A., Katsanos, K., Treating femoropopliteal disease: established and emerging technologies. Semin Interv Radiol 31 (2014), 345–352.
2. 2 Tepe, G., Zeller, T., Albrecht, T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008), 689–699.
3. 3 Katsanos, K., Spiliopoulos, S., Karunanithy, N., Krokidis, M., Sabharwal, T., Taylor, P., Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg 59 (2014), 1123–1133.e8.
4. 4 Giacoppo, D., Cassese, S., Harada, Y., et al. Drug–coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta–analysis of randomized clinical trials. J Am Coll Cardiol Intv 9 (2016), 1731–1742.
5. 5 Katsanos, K., Spiliopoulos, S., Paraskevopoulos, I., Diamantopoulos, A., Karnabatidis, D., Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther 23 (2016), 356–370.
6. 6 Tepe, G., Laird, J., Schneider, P., et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131 (2015), 495–502.
7. 7 Announcement. Second Interim Analysis of ILLUMENATE Global Study Presented for Spectranetics’ Stellarex DCB. Endovascular Today 2016;June 1st.
8. 8 Rosenfield, K., Jaff, M.R., White, C.J., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
9. 9 Gongora, C.A., Shibuya, M., Wessler, J.D., et al. Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis. J Am Coll Cardiol Intv 8 (2015), 1115–1123.
10. 10 Ng, V.G., Mena, C., Pietras, C., Lansky, A.J., Local delivery of paclitaxel in the treatment of peripheral arterial disease. Eur J Clin Invest 45 (2015), 333–345.
11. 11 Yazdani, S.K., Pacheco, E., Nakano, M., et al. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Catheter Cardiovasc Interv 83 (2014), 132–140.
12. 12 Melder R. In.Pact drug-eluting balloon technology and pre-clinical findings. Presented at: EUROPCR; May 2012: Paris, France. EUROPCR.
13. 13 Axel, D.I., Kunert, W., Goggelmann, C., et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96 (1997), 636–645.
14. 14 Katsanos, K., Geisler, B.P., Garner, A.M., Zayed, H., Cleveland, T., Pietzsch, J.B., Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open, 6, 2016, e011245.